Often, drug development has focused on small molecules, but peptide collaborations are progressively demonstrating momentum. This new approach involves combining peptidic sequences with alternative therapeutic methods to confront complex illness pathways. By employing the distinctive properties of peptidic compounds – such as significant precisio